# Mayinglong Pharmaceutical Group Co Ltd – FDA Inspection, Apr 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/mayinglong-pharmaceutical-group-co-ltd/afbc3f22-1afe-4d7c-b2ac-dfa83829e9db
Source feed: FDA_Inspections

> FDA inspection 1051249 of Mayinglong Pharmaceutical Group Co Ltd, April 13, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1051249
- Company Name: Mayinglong Pharmaceutical Group Co Ltd
- Inspection Date: 2018-04-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1264613 - 2025-03-14](https://www.keypedia.com/records/fda_inspections/mayinglong-pharmaceutical-group-co-ltd/1ad73c7c-df72-408e-a5c5-66c29048c1d6)
- FDA Inspection 955742 - 2015-12-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kham-phommachanh/cc7e728e-d2a1-469d-be3a-4f5fdd43b2dc)

Company: https://www.keypedia.com/companies/mayinglong-pharmaceutical-group-co-ltd/74ea2093-120b-44f4-9f36-13b2ec118a13

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c